Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng-Gee Lim

Showing results (51-60 of 219) with videos related to

Pageof 22
Sort By:
RNA Biology|January 24, 2014
RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumorsQueenie Wing-Lei Wong, Jia Li, Sheng Rong Ng, et al.
Journal of Gastroenterology and Hepatology|July 25, 2007
Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic populationReuben-Km Wong, Seng-Gee Lim, Aileen Wee, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 9, 2008
Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinomaChiung-Ing Wong, Hui-Ling Yap, Seng-Gee Lim, et al.
Journal of Hepatology|February 9, 2010
A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis BAnthony T Tan, Sarene Koh, Winnie Goh, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implicationsXiao-Jian Zhou, Seng-Gee Lim, Deborah M Lloyd, et al.
Journal of Gastroenterology and Hepatology|June 15, 2007
How should we manage patients with non-alcoholic fatty liver disease in 2007?Henry L-Y Chan, H Janaka de Silva, Nancy W-Y Leung, et al.
Journal of Viral Hepatitis|March 15, 2020
The efficacy of hepatitis B treatments in achieving HBsAg seroclearance: A systematic review and meta-analysisMariana Alves Fonseca, Joanna Zhi Jie Ling, Omar Al-Siyabi, et al.
Antisense & Nucleic Acid Drug Development|September 20, 2002
Intracellular inhibition of hepatitis B virus S gene expression by chimeric DNA-RNA phosphorothioate minimized ribozymeTheresa May Chin Tan, Lei Zhou, Sandrine Houssais, et al.
World Journal of Gastroenterology|July 23, 2005
Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhoticsYock-Young Dan, Chun-Tao Wai, Yin-Mei Lee, et al.
Molecular Cancer|March 24, 2012
Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinomaWeijie Poh, Winnie Wong, Huimin Ong, et al.
Pageof 22

Showing results (51-60 of 219) with videos related to

Sort By:
Pageof 22
RNA Biology|January 24, 2014
RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumorsQueenie Wing-Lei Wong, Jia Li, Sheng Rong Ng, et al.
Journal of Gastroenterology and Hepatology|July 25, 2007
Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic populationReuben-Km Wong, Seng-Gee Lim, Aileen Wee, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 9, 2008
Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinomaChiung-Ing Wong, Hui-Ling Yap, Seng-Gee Lim, et al.
Journal of Hepatology|February 9, 2010
A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis BAnthony T Tan, Sarene Koh, Winnie Goh, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implicationsXiao-Jian Zhou, Seng-Gee Lim, Deborah M Lloyd, et al.
Journal of Gastroenterology and Hepatology|June 15, 2007
How should we manage patients with non-alcoholic fatty liver disease in 2007?Henry L-Y Chan, H Janaka de Silva, Nancy W-Y Leung, et al.
Journal of Viral Hepatitis|March 15, 2020
The efficacy of hepatitis B treatments in achieving HBsAg seroclearance: A systematic review and meta-analysisMariana Alves Fonseca, Joanna Zhi Jie Ling, Omar Al-Siyabi, et al.
Antisense & Nucleic Acid Drug Development|September 20, 2002
Intracellular inhibition of hepatitis B virus S gene expression by chimeric DNA-RNA phosphorothioate minimized ribozymeTheresa May Chin Tan, Lei Zhou, Sandrine Houssais, et al.
World Journal of Gastroenterology|July 23, 2005
Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhoticsYock-Young Dan, Chun-Tao Wai, Yin-Mei Lee, et al.
Molecular Cancer|March 24, 2012
Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinomaWeijie Poh, Winnie Wong, Huimin Ong, et al.
Pageof 22